Click for best price
Viral Vector Vaccine Market Size, Share 2024
The global Viral Vector and Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Adenovirus Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Viral Vector and Vaccine include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Vaccine. This report contains market size and forecasts of Viral Vector and Vaccine in global, including the following market information:
Global Viral Vector and Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Viral Vector and Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Viral Vector and Vaccine companies in 2023 (%)
We has surveyed the Viral Vector and Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector and Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, by Type, 2023 (%)
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Global Viral Vector and Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, by Application, 2023 (%)
Research Institutes
Biopharmaceutical Companies
Others
Global Viral Vector and Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector and Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Viral Vector and Vaccine revenues share in global market, 2023 (%)
Key companies Viral Vector and Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Viral Vector and Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vector and Vaccine, market overview.
Chapter 2: Global Viral Vector and Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Viral Vector and Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vector and Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Viral Vector and Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Vector and Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Vector and Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vector and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector and Vaccine Overall Market Size
2.1 Global Viral Vector and Vaccine Market Size: 2023 VS 2030
2.2 Global Viral Vector and Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Viral Vector and Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Viral Vector and Vaccine Players in Global Market
3.2 Top Global Viral Vector and Vaccine Companies Ranked by Revenue
3.3 Global Viral Vector and Vaccine Revenue by Companies
3.4 Global Viral Vector and Vaccine Sales by Companies
3.5 Global Viral Vector and Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Viral Vector and Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Viral Vector and Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vector and Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Viral Vector and Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vector and Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vector and Vaccine Market Size Markets, 2023 & 2030
4.1.2 Adenovirus
4.1.3 Fowlpox Virus
4.1.4 Attenuated Yellow Fever
4.1.5 Vaccinia Virus Vectors
4.2 By Type - Global Viral Vector and Vaccine Revenue & Forecasts
4.2.1 By Type - Global Viral Vector and Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Viral Vector and Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Viral Vector and Vaccine Sales & Forecasts
4.3.1 By Type - Global Viral Vector and Vaccine Sales, 2019-2024
4.3.2 By Type - Global Viral Vector and Vaccine Sales, 2025-2030
4.3.3 By Type - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Viral Vector and Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vector and Vaccine Market Size, 2023 & 2030
5.1.2 Research Institutes
5.1.3 Biopharmaceutical Companies
5.1.4 Others
5.2 By Application - Global Viral Vector and Vaccine Revenue & Forecasts
5.2.1 By Application - Global Viral Vector and Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Viral Vector and Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Viral Vector and Vaccine Sales & Forecasts
5.3.1 By Application - Global Viral Vector and Vaccine Sales, 2019-2024
5.3.2 By Application - Global Viral Vector and Vaccine Sales, 2025-2030
5.3.3 By Application - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Viral Vector and Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Viral Vector and Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Viral Vector and Vaccine Revenue & Forecasts
6.2.1 By Region - Global Viral Vector and Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Viral Vector and Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Viral Vector and Vaccine Sales & Forecasts
6.3.1 By Region - Global Viral Vector and Vaccine Sales, 2019-2024
6.3.2 By Region - Global Viral Vector and Vaccine Sales, 2025-2030
6.3.3 By Region - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Viral Vector and Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Viral Vector and Vaccine Sales, 2019-2030
6.4.3 US Viral Vector and Vaccine Market Size, 2019-2030
6.4.4 Canada Viral Vector and Vaccine Market Size, 2019-2030
6.4.5 Mexico Viral Vector and Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Viral Vector and Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Viral Vector and Vaccine Sales, 2019-2030
6.5.3 Germany Viral Vector and Vaccine Market Size, 2019-2030
6.5.4 France Viral Vector and Vaccine Market Size, 2019-2030
6.5.5 U.K. Viral Vector and Vaccine Market Size, 2019-2030
6.5.6 Italy Viral Vector and Vaccine Market Size, 2019-2030
6.5.7 Russia Viral Vector and Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Viral Vector and Vaccine Market Size, 2019-2030
6.5.9 Benelux Viral Vector and Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Viral Vector and Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Viral Vector and Vaccine Sales, 2019-2030
6.6.3 China Viral Vector and Vaccine Market Size, 2019-2030
6.6.4 Japan Viral Vector and Vaccine Market Size, 2019-2030
6.6.5 South Korea Viral Vector and Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Viral Vector and Vaccine Market Size, 2019-2030
6.6.7 India Viral Vector and Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Viral Vector and Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Viral Vector and Vaccine Sales, 2019-2030
6.7.3 Brazil Viral Vector and Vaccine Market Size, 2019-2030
6.7.4 Argentina Viral Vector and Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Viral Vector and Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Viral Vector and Vaccine Sales, 2019-2030
6.8.3 Turkey Viral Vector and Vaccine Market Size, 2019-2030
6.8.4 Israel Viral Vector and Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Viral Vector and Vaccine Market Size, 2019-2030
6.8.6 UAE Viral Vector and Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 ABL
7.1.1 ABL Company Summary
7.1.2 ABL Business Overview
7.1.3 ABL Viral Vector and Vaccine Major Product Offerings
7.1.4 ABL Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 ABL Key News & Latest Developments
7.2 Addgene
7.2.1 Addgene Company Summary
7.2.2 Addgene Business Overview
7.2.3 Addgene Viral Vector and Vaccine Major Product Offerings
7.2.4 Addgene Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Addgene Key News & Latest Developments
7.3 Aldevron
7.3.1 Aldevron Company Summary
7.3.2 Aldevron Business Overview
7.3.3 Aldevron Viral Vector and Vaccine Major Product Offerings
7.3.4 Aldevron Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Aldevron Key News & Latest Developments
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Company Summary
7.4.2 Boehringer Ingelheim International GmbH Business Overview
7.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Major Product Offerings
7.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.5 Brammer Bio
7.5.1 Brammer Bio Company Summary
7.5.2 Brammer Bio Business Overview
7.5.3 Brammer Bio Viral Vector and Vaccine Major Product Offerings
7.5.4 Brammer Bio Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Brammer Bio Key News & Latest Developments
7.6 Charles River Laboratories
7.6.1 Charles River Laboratories Company Summary
7.6.2 Charles River Laboratories Business Overview
7.6.3 Charles River Laboratories Viral Vector and Vaccine Major Product Offerings
7.6.4 Charles River Laboratories Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Charles River Laboratories Key News & Latest Developments
7.7 Creative-Biogene
7.7.1 Creative-Biogene Company Summary
7.7.2 Creative-Biogene Business Overview
7.7.3 Creative-Biogene Viral Vector and Vaccine Major Product Offerings
7.7.4 Creative-Biogene Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Creative-Biogene Key News & Latest Developments
7.8 Fujifilm Corporation
7.8.1 Fujifilm Corporation Company Summary
7.8.2 Fujifilm Corporation Business Overview
7.8.3 Fujifilm Corporation Viral Vector and Vaccine Major Product Offerings
7.8.4 Fujifilm Corporation Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 Fujifilm Corporation Key News & Latest Developments
7.9 General Electric
7.9.1 General Electric Company Summary
7.9.2 General Electric Business Overview
7.9.3 General Electric Viral Vector and Vaccine Major Product Offerings
7.9.4 General Electric Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 General Electric Key News & Latest Developments
7.10 MerckKGaA
7.10.1 MerckKGaA Company Summary
7.10.2 MerckKGaA Business Overview
7.10.3 MerckKGaA Viral Vector and Vaccine Major Product Offerings
7.10.4 MerckKGaA Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 MerckKGaA Key News & Latest Developments
7.11 Novasep
7.11.1 Novasep Company Summary
7.11.2 Novasep Viral Vector and Vaccine Business Overview
7.11.3 Novasep Viral Vector and Vaccine Major Product Offerings
7.11.4 Novasep Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.11.5 Novasep Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Viral Vector and Vaccine Business Overview
7.12.3 Pfizer Viral Vector and Vaccine Major Product Offerings
7.12.4 Pfizer Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.12.5 Pfizer Key News & Latest Developments
7.13 Spark Therapeutics
7.13.1 Spark Therapeutics Company Summary
7.13.2 Spark Therapeutics Viral Vector and Vaccine Business Overview
7.13.3 Spark Therapeutics Viral Vector and Vaccine Major Product Offerings
7.13.4 Spark Therapeutics Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.13.5 Spark Therapeutics Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Major Product Offerings
7.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
7.15 Waisman Biomanufacturing
7.15.1 Waisman Biomanufacturing Company Summary
7.15.2 Waisman Biomanufacturing Business Overview
7.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Major Product Offerings
7.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.15.5 Waisman Biomanufacturing Key News & Latest Developments
8 Global Viral Vector and Vaccine Production Capacity, Analysis
8.1 Global Viral Vector and Vaccine Production Capacity, 2019-2030
8.2 Viral Vector and Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Viral Vector and Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Viral Vector and Vaccine Supply Chain Analysis
10.1 Viral Vector and Vaccine Industry Value Chain
10.2 Viral Vector and Vaccine Upstream Market
10.3 Viral Vector and Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Viral Vector and Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Viral Vector and Vaccine in Global Market
Table 2. Top Viral Vector and Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Viral Vector and Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Viral Vector and Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global Viral Vector and Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global Viral Vector and Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Viral Vector and Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Viral Vector and Vaccine Product Type
Table 9. List of Global Tier 1 Viral Vector and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vector and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Viral Vector and Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Viral Vector and Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Viral Vector and Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global Viral Vector and Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Viral Vector and Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Viral Vector and Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Viral Vector and Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global Viral Vector and Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Viral Vector and Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Viral Vector and Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Viral Vector and Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global Viral Vector and Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Viral Vector and Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Viral Vector and Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America Viral Vector and Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Viral Vector and Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Viral Vector and Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Viral Vector and Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Viral Vector and Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Viral Vector and Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Viral Vector and Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Viral Vector and Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Viral Vector and Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America Viral Vector and Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Viral Vector and Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Viral Vector and Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Viral Vector and Vaccine Sales, (K Units), 2025-2030
Table 46. ABL Company Summary
Table 47. ABL Viral Vector and Vaccine Product Offerings
Table 48. ABL Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. ABL Key News & Latest Developments
Table 50. Addgene Company Summary
Table 51. Addgene Viral Vector and Vaccine Product Offerings
Table 52. Addgene Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Addgene Key News & Latest Developments
Table 54. Aldevron Company Summary
Table 55. Aldevron Viral Vector and Vaccine Product Offerings
Table 56. Aldevron Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Aldevron Key News & Latest Developments
Table 58. Boehringer Ingelheim International GmbH Company Summary
Table 59. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Product Offerings
Table 60. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Boehringer Ingelheim International GmbH Key News & Latest Developments
Table 62. Brammer Bio Company Summary
Table 63. Brammer Bio Viral Vector and Vaccine Product Offerings
Table 64. Brammer Bio Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Brammer Bio Key News & Latest Developments
Table 66. Charles River Laboratories Company Summary
Table 67. Charles River Laboratories Viral Vector and Vaccine Product Offerings
Table 68. Charles River Laboratories Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Charles River Laboratories Key News & Latest Developments
Table 70. Creative-Biogene Company Summary
Table 71. Creative-Biogene Viral Vector and Vaccine Product Offerings
Table 72. Creative-Biogene Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Creative-Biogene Key News & Latest Developments
Table 74. Fujifilm Corporation Company Summary
Table 75. Fujifilm Corporation Viral Vector and Vaccine Product Offerings
Table 76. Fujifilm Corporation Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Fujifilm Corporation Key News & Latest Developments
Table 78. General Electric Company Summary
Table 79. General Electric Viral Vector and Vaccine Product Offerings
Table 80. General Electric Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. General Electric Key News & Latest Developments
Table 82. MerckKGaA Company Summary
Table 83. MerckKGaA Viral Vector and Vaccine Product Offerings
Table 84. MerckKGaA Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. MerckKGaA Key News & Latest Developments
Table 86. Novasep Company Summary
Table 87. Novasep Viral Vector and Vaccine Product Offerings
Table 88. Novasep Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Novasep Key News & Latest Developments
Table 90. Pfizer Company Summary
Table 91. Pfizer Viral Vector and Vaccine Product Offerings
Table 92. Pfizer Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Pfizer Key News & Latest Developments
Table 94. Spark Therapeutics Company Summary
Table 95. Spark Therapeutics Viral Vector and Vaccine Product Offerings
Table 96. Spark Therapeutics Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Spark Therapeutics Key News & Latest Developments
Table 98. Thermo Fisher Scientific Company Summary
Table 99. Thermo Fisher Scientific Viral Vector and Vaccine Product Offerings
Table 100. Thermo Fisher Scientific Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Thermo Fisher Scientific Key News & Latest Developments
Table 102. Waisman Biomanufacturing Company Summary
Table 103. Waisman Biomanufacturing Viral Vector and Vaccine Product Offerings
Table 104. Waisman Biomanufacturing Viral Vector and Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Waisman Biomanufacturing Key News & Latest Developments
Table 106. Viral Vector and Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Viral Vector and Vaccine Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Viral Vector and Vaccine Production by Region, 2019-2024 (K Units)
Table 109. Global Viral Vector and Vaccine Production by Region, 2025-2030 (K Units)
Table 110. Viral Vector and Vaccine Market Opportunities & Trends in Global Market
Table 111. Viral Vector and Vaccine Market Drivers in Global Market
Table 112. Viral Vector and Vaccine Market Restraints in Global Market
Table 113. Viral Vector and Vaccine Raw Materials
Table 114. Viral Vector and Vaccine Raw Materials Suppliers in Global Market
Table 115. Typical Viral Vector and Vaccine Downstream
Table 116. Viral Vector and Vaccine Downstream Clients in Global Market
Table 117. Viral Vector and Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Viral Vector and Vaccine Segment by Type in 2023
Figure 2. Viral Vector and Vaccine Segment by Application in 2023
Figure 3. Global Viral Vector and Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Viral Vector and Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Viral Vector and Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. Viral Vector and Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Viral Vector and Vaccine Revenue in 2023
Figure 9. By Type - Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global Viral Vector and Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global Viral Vector and Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Viral Vector and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Viral Vector and Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 23. US Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 28. Germany Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 37. China Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Viral Vector and Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Viral Vector and Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Viral Vector and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Viral Vector and Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Viral Vector and Vaccine by Region, 2023 VS 2030
Figure 54. Viral Vector and Vaccine Industry Value Chain
Figure 55. Marketing Channels
